NARA — Pangenomic Health Share News
0.000.00%
- CA$4.11m
- CA$4.82m
PanGenomic Health Inc: PanGenomic Health Announces Withdrawal from AQSE
Brief: Pangenomic Health Signs Letter Of Intent With Crescita Capital For $5 Mln Equity Drawdown Facility
PanGenomic Health Inc: PanGenomic Health Signs Letter of Intent with Crescita Capital for $5 Million Equity Drawdown Facility
PanGenomic Health Inc: PanGenomic Health Announces Q3 Financial Results
PanGenomic Health Inc: PanGenomic Health Intends to Close Shares for Debt Settlement
PanGenomic Health Inc: PanGenomic Health Announces Financial Results for Half Year Ended 30 June 2023
PanGenomic Health Inc: Board Changes
PanGenomic Health Inc: PanGenomic Health Provides Update for NARA Product and Conversational AI
PanGenomic Health Inc: PanGenomic Health Signs Non-Binding Letter of intent for an Exclusive Special Purpose Licence of the CyberPatient AI Medical Education Platform
PanGenomic Health Inc: Annual Financial Results
PanGenomic Health Inc: AGM Results
Brief: Pangenomic Health Subsidiary Signs Master Services Agreement With Psy Integrated And Announces Repricing Of Outstanding Warrants
Brief: Pangenomic Health Subsidiary, MUJN Diagnostics, Announces The Engagement Of Hemex Health To Assist In The Development Of Brain Health Diagnostics System
Brief: Pangenomic Health Announces Filing Of Business Acquisition Report For Mindleap Health
Brief: PanGenomic Health Announces Intention To Dual List On The UK Aquis Stock Exchange Growth Market
Brief: Pangenomic Health Subsidiary Signs Non-Binding MoU With Psy Integrated Health For Diagnostic Testing Joint Venture
Brief: Pangenomic Health Enters Into Definitive Agreement For Acquisition Of Mindleap Health